tranexamicacidReversal ofthrombolytic agentused for short periodsin patients withhemophilia to preventor decrease breedingform tooth extraction ormenorrhagia.HomeostasisProcess thatmaintains theintegrity ofthe vascularcompartment.DVTand PEHeparin isgivenprophylacticallyto patients toprevent theseClopidogrelprototype Adenosinediphosphate receptorantagonist thatirreversibly blocks theADP receptor onplatelet cell surface.3QSEN Alert: Thenurse should holdthe dose of warfarinif the INR is abovethis number andnotify the healthcare providerHeparin inducedthrombocytopenia(HIT)A potentially life-threateningcomplication of heparinadministration leadingto a decrease inplatelet count anddetectable HITantibodiesRivaroxabandirect factor Xainhibitor prototypethat inhibits plateletactivation andformation of fibrinclotting by inhibitionof factor XaPCCReversal ofwarfarin overdosewith acute majorbleeding or inneed of emergentsurgeryActionofwarfarinActs in theliver topreventsynthesis ofvitamin KdabigatranThe onlyoral directthrombininhibitorProtamineSulfateAntidoteforheparinHemorrhagemajor sideeffect ofHeparintherapywarfarinPrototypevitamin KantagonistThrombolysisDissolutionof bloodclotsDisseminatedintravascularcoagulation(DIC)Heparin is used totreat this life-threatening conditioncharacterized bywidespread clotting,which depletes theblood of coagulationfactors.IdarucizumabAntidotefordabigatranPlasminogenAn inactive proteinpresent in many bodytissues and fluids thatis bound to fibrin andbecomes acomponent of a bloodclotHeparininhibits theconversion ofprothrombin tothrombin andprevents thrombusformationalteplaseprototypethrombolyticdrugPTTandINRLaboratorytests used tomanagetherapeuticrange ofwarfarinaPTTlaboratory testused to see ifheparin iswithintherapeuticrangeVitaminKantidoteforwarfarinAminocaproicacidReversal ofthrombolytic agentused in cardiacsurgery, blooddisorders, hepaticcirrhosis,prostatectomy, andneoplastic disordersThrombolyticDrugsagentsthatdissolveblood clotstranexamicacidReversal ofthrombolytic agentused for short periodsin patients withhemophilia to preventor decrease breedingform tooth extraction ormenorrhagia.HomeostasisProcess thatmaintains theintegrity ofthe vascularcompartment.DVTand PEHeparin isgivenprophylacticallyto patients toprevent theseClopidogrelprototype Adenosinediphosphate receptorantagonist thatirreversibly blocks theADP receptor onplatelet cell surface.3QSEN Alert: Thenurse should holdthe dose of warfarinif the INR is abovethis number andnotify the healthcare providerHeparin inducedthrombocytopenia(HIT)A potentially life-threateningcomplication of heparinadministration leadingto a decrease inplatelet count anddetectable HITantibodiesRivaroxabandirect factor Xainhibitor prototypethat inhibits plateletactivation andformation of fibrinclotting by inhibitionof factor XaPCCReversal ofwarfarin overdosewith acute majorbleeding or inneed of emergentsurgeryActionofwarfarinActs in theliver topreventsynthesis ofvitamin KdabigatranThe onlyoral directthrombininhibitorProtamineSulfateAntidoteforheparinHemorrhagemajor sideeffect ofHeparintherapywarfarinPrototypevitamin KantagonistThrombolysisDissolutionof bloodclotsDisseminatedintravascularcoagulation(DIC)Heparin is used totreat this life-threatening conditioncharacterized bywidespread clotting,which depletes theblood of coagulationfactors.IdarucizumabAntidotefordabigatranPlasminogenAn inactive proteinpresent in many bodytissues and fluids thatis bound to fibrin andbecomes acomponent of a bloodclotHeparininhibits theconversion ofprothrombin tothrombin andprevents thrombusformationalteplaseprototypethrombolyticdrugPTTandINRLaboratorytests used tomanagetherapeuticrange ofwarfarinaPTTlaboratory testused to see ifheparin iswithintherapeuticrangeVitaminKantidoteforwarfarinAminocaproicacidReversal ofthrombolytic agentused in cardiacsurgery, blooddisorders, hepaticcirrhosis,prostatectomy, andneoplastic disordersThrombolyticDrugsagentsthatdissolveblood clots

Chapter 9 Drug Therapy for Coagulation Disorders - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Reversal of thrombolytic agent used for short periods in patients with hemophilia to prevent or decrease breeding form tooth extraction or menorrhagia.
    tranexamic acid
  2. Process that maintains the integrity of the vascular compartment.
    Homeostasis
  3. Heparin is given prophylactically to patients to prevent these
    DVT and PE
  4. prototype Adenosine diphosphate receptor antagonist that irreversibly blocks the ADP receptor on platelet cell surface.
    Clopidogrel
  5. QSEN Alert: The nurse should hold the dose of warfarin if the INR is above this number and notify the health care provider
    3
  6. A potentially life-threatening complication of heparin administration leading to a decrease in platelet count and detectable HIT antibodies
    Heparin induced thrombocytopenia (HIT)
  7. direct factor Xa inhibitor prototype that inhibits platelet activation and formation of fibrin clotting by inhibition of factor Xa
    Rivaroxaban
  8. Reversal of warfarin overdose with acute major bleeding or in need of emergent surgery
    PCC
  9. Acts in the liver to prevent synthesis of vitamin K
    Action of warfarin
  10. The only oral direct thrombin inhibitor
    dabigatran
  11. Antidote for heparin
    Protamine Sulfate
  12. major side effect of Heparin therapy
    Hemorrhage
  13. Prototype vitamin K antagonist
    warfarin
  14. Dissolution of blood clots
    Thrombolysis
  15. Heparin is used to treat this life-threatening condition characterized by widespread clotting, which depletes the blood of coagulation factors.
    Disseminated intravascular coagulation (DIC)
  16. Antidote for dabigatran
    Idarucizumab
  17. An inactive protein present in many body tissues and fluids that is bound to fibrin and becomes a component of a blood clot
    Plasminogen
  18. inhibits the conversion of prothrombin to thrombin and prevents thrombus formation
    Heparin
  19. prototype thrombolytic drug
    alteplase
  20. Laboratory tests used to manage therapeutic range of warfarin
    PTT and INR
  21. laboratory test used to see if heparin is within therapeutic range
    aPTT
  22. antidote for warfarin
    Vitamin K
  23. Reversal of thrombolytic agent used in cardiac surgery, blood disorders, hepatic cirrhosis, prostatectomy, and neoplastic disorders
    Aminocaproic acid
  24. agents that dissolve blood clots
    Thrombolytic Drugs